Farzan Nima bought KROS
June 3, 2026 · Form 4 insider transaction
Farzan Nima bought 7,142 shares of Keros Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,142
Price
$0.00
Total value
N/A
InsiderFarzan Nima
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 3, 2026
Filing dateJune 5, 2026
Shares owned after12,392
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a restricted stock unit ("RSU") award. The RSUs fully vest on the earlier of (A) June 3, 2027 and (B) the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person continuing to provide service through each such date.